Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

In 2024, Russians applied for a Schengen visa more than 600,000 times. Consulates of three European countries in Moscow accounted for 64% of the requests. Which countries were more likely to issue ...